Form 13-F position report

ARENA PHARMACEUTICALS INC COM

Reported by Avoro Capital Advisors LLC

Manager portfolio Source filing
ARNA CUSIP 040047607 Manager CIK 0001633313
Latest reported change

Reported 0 shares, down 1,235,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 8 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q1 2022 Reduced 0 -1,235,000 (-100.0%) 0 $0 2022-05-16
Q4 2021 Reduced 1,235,000 -2,190,000 (-63.9%) 1.95% $114,781,000 2022-02-14
Q3 2021 Reduced 3,425,000 -650,000 (-16.0%) 3.2% $203,959,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

306 managers reported ARENA PHARMACEUTICALS INC COM for Q1 2022.

Manager Activity Shares Change % of reported 13F Reported value Tenure
Penserra Capital Management LLC Reduced 0 -4,791 0 $0 11 qtrs
DCF Advisers LLC Reduced 0 -5,000 0 $0 9 qtrs
Plante Moran Financial Advisors LLC Reduced 0 -105 0 $0 20 qtrs
CARLSON CAPITAL L P Reduced 0 -110,000 0 $0 2 qtrs
Parallel Advisors LLC Reduced 0 -267 0 $0 6 qtrs
Ameritas Investment Partners Inc Reduced 0 -4,824 0 $0 20 qtrs
OSBORNE PARTNERS CAPITAL MANAGEMENT LLC Reduced 0 -3,489 0 $0 4 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 0 -190,490 0 $0 18 qtrs
Nicholas Investment Partners LP Reduced 0 -239,119 0 $0 6 qtrs
Zurcher Kantonalbank Zurich Cantonalbank Reduced 0 -7,671 0 $0 20 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
Common

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.